CSIMarket Company Name, Ticker, Suppliers, else..


Vaxcyte Inc   (NASDAQ: PCVX)
Other Ticker:  
 

Vaxcyte Inc

PCVX's Fundamental analysis



Vaxcyte Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Vaxcyte Inc net loss increased from $-93 millions, to $-103 millions in III. Quarter 2024,

• More on PCVX's Growth


Vaxcyte Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 22.35 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.4.


• More on PCVX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 27.63

Vaxcyte Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 22.35 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.4.

Vaxcyte Inc Price to Book Ratio is at 3.3 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01

• More on PCVX's Valuation

•  Market Capitalization (Millions $) 11,292
•  Shares Outstanding (Millions) 124
•  Employees 206
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -508
•  Cash Flow (TTM) (Millions $) 505
•  Capital Exp. (TTM) (Millions $) -24
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 27.63

•  Market Capitalization (Millions $) 11,292
•  Shares Outstanding (Millions) 124
•  Employees 206
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -508
•  Cash Flow (TTM) (Millions $) 505
•  Capital Exp. (TTM) (Millions $) -24





  Ratio
•   Capital Ratio (MRQ) 36.16
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.02
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com